VERU INC. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VERU INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2024-03-31 was $3.63M, a 5.30% decline year-over-year.
- VERU INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2023-12-31 was $3.41M, a 29.69% decline year-over-year.
- VERU INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2023-06-30 was $4.55M, a 56.33% increase year-over-year.
- VERU INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2023-03-31 was $3.84M, a 80.60% increase year-over-year.
- VERU INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2023 was $17.92M, a 59.38% increase from fiscal 2022.
- VERU INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2022 was $11.24M, a 122.61% increase from fiscal 2021.
- VERU INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2021 was $5.05M, a 90.85% increase from fiscal 2020.
- VERU INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2020 was $2.65M, a 38.83% increase from fiscal 2019.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2024-03-31 | $3.63M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $3.41M 10-Q · filed 2024-05-08 | |
| 2023-09-30 | $17.92M 10-K/A · filed 2024-04-01 | |
| 2023-06-30 | $4.55M 10-Q/A · filed 2023-11-15 | |
| 2023-03-31 | $3.84M 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $4.85M 10-Q · filed 2024-05-08 | |
| 2022-09-30 | $11.24M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $2.91M 10-Q/A · filed 2023-11-15 | |
| 2022-03-31 | $2.12M 10-Q/A · filed 2023-11-15 | |
| 2021-12-31 | $1.88M 10-Q/A · filed 2023-11-15 | |
| 2021-09-30 | $5.05M 10-K · filed 2022-12-05 | |
| 2021-06-30 | $1.90M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $1.00M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $785.30K 10-Q · filed 2022-08-11 | |
| 2020-09-30 | $2.65M 10-K · filed 2021-12-02 | |
| 2020-06-30 | $685.31K 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $681.68K 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $614.50K 10-Q · filed 2021-08-12 | |
| 2019-09-30 | $1.91M 10-K · filed 2020-12-10 | |
| 2019-06-30 | $468.21K 10-Q · filed 2020-08-13 | $1.94M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $496.21K 10-Q · filed 2020-08-13 | $1.93M derived: sum of 4 quarters · filed 2020-08-13 |
| 2018-12-31 | $417.26K 10-Q · filed 2020-08-13 | $1.85M derived: sum of 4 quarters · filed 2020-08-13 |
| 2018-09-30 | $559.23K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $1.64M 10-K · filed 2019-12-12 |
| 2018-06-30 | $459.97K 10-Q · filed 2019-08-08 | $1.42M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $411.85K 10-Q · filed 2019-08-08 | $1.03M derived: sum of 4 quarters · filed 2019-08-08 |
| 2017-12-31 | $207.45K 10-Q · filed 2019-08-08 | $684.62K derived: sum of 4 quarters · filed 2019-08-08 |
| 2017-09-30 | $337.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $780.93K 10-K · filed 2018-12-13 |
| 2017-06-30 | $69.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | |
| 2017-03-31 | $70.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | |
| 2016-12-31 | $303.77K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $455.62K 10-K · filed 2018-01-02 | |
| 2015-09-30 | $722.65K 10-K · filed 2018-01-02 | |
| 2014-09-30 | $909.45K 10-K · filed 2016-12-12 | |
| 2013-09-30 | $701.02K 10-K · filed 2015-12-02 | |
| 2012-09-30 | $817.48K 10-K · filed 2014-12-02 | |
| 2011-09-30 | $806.58K 10-K · filed 2013-12-03 | |
| 2010-09-30 | $357.82K 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |